- Poster presentation
- Open Access
Development of diabetes mellitus after hematopoietic stem cell transplantation for childhood leukemia
International Journal of Pediatric Endocrinology volume 2015, Article number: P28 (2015)
We investigated clinical features of newly diagnosed diabetes mellitus (DM) after hematopoietic stem cell transplantation (HSCT) for treatment of childhood leukemia.
Between April 2009 and March 2014, total 124 patients (73 males, 51 females) were visited the clinic of pediatric endocrinology for routine follow-up check after HSCT for leukemia. Among them, five patients developed DM (4 males, 1 female). We retrospectively reviewed medical charts including laboratory findings.
Three patients were diagnosed as acute lymphoblastic leukemia who received total body irradiation and chemotherapy. The other two patients were diagnosed as acute myeloblastic leukemia. The mean age at HSCT was 8.0 ± 4.2 years. Four out of five patients developed chronic graft-versus-host disease (GVHD) and treated with steroid more than 2 years. The mean age at diagnosis of DM was 15.8 ± 1.8 years and the time interval between HSCT and DM was 7.8 ± 4.4 years. Three patients showed obesity depend on body mass index (>95th percentile for sex and age). No one showed antibodies related with pancreatic β-cell. All five patients showed hyperinsulinemia with mean fasting insulin levels at diagnosis of DM was 13.3 ± 9.2 μIU/mL. The mean homeostasis model assessment of insulin resistance index (HOMA-IR) of patients was 4.39 ± 2.01.
GVHD, long-term steroid treatment and insulin resistance seem to be close related to develop of DM after HSCT for treatment of childhood leukemia.
About this article
Cite this article
Ah Jung, I., Jeon, Y.J., Cho, W.K. et al. Development of diabetes mellitus after hematopoietic stem cell transplantation for childhood leukemia. Int J Pediatr Endocrinol 2015, P28 (2015). https://doi.org/10.1186/1687-9856-2015-S1-P28
- Diabetes Mellitus
- Insulin Resistance
- Acute Lymphoblastic Leukemia
- Hematopoietic Stem Cell Transplantation